Pharmacometrics has traditionally relied on diverse tools and skills to tackle unique challenges, often without predefined solutions. With PopPK analysis now standard for regulatory submissions and expected by the FDA, harmonizing workflows across tools is critical to improving research quality and efficiency as model-informed drug development (MIDD) gains traction.
Pirana PMX Modeling Workbench provides a unified framework for pharmacometric modeling, streamlining development and evaluation. Its machine learning capabilities accelerate model selection, enabling faster, more efficient workflows. By improving organization, insight, and decision-making, Pirana helps deliver higher-quality submissions, faster.
